miR147 promotes mucosal integrity and healing in intestinal inflammation

Agnieszka K Czopik1, Arash Dabiri1, Chia-Hao Tung2

  • 1Department of Anesthesiology, Critical Care and Pain Medicine, McGovern Medical School.

JCI Insight
|September 16, 2025
PubMed

Insights

MicroRNA 147 (miR147) protects the gut barrier and aids healing during intestinal inflammation. Its deficiency worsens colitis, highlighting miR147 as a potential therapeutic target for inflammatory bowel disease.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Immunology

Background:

  • The intestinal epithelium is a critical barrier regulated by microRNAs (miRNAs).
  • MicroRNAs play a role in maintaining mucosal homeostasis and controlling inflammatory responses.
  • Understanding miRNA functions is key to addressing inflammatory bowel disease (IBD).

Purpose of the Study:

  • To investigate the role of microRNA 147 (miR147) in intestinal inflammation and mucosal healing.
  • To identify molecular targets and mechanisms underlying miR147's function in the gut.
  • To explore the therapeutic potential of miR147 in inflammatory conditions.

Main Methods:

  • Utilized a miR147tdTomato reporter mouse model for studying miR147 expression.
  • Generated mice with general or intestinal epithelial deletion of miR147.
  • Performed RNA sequencing, spatial transcriptomics, and single-cell transcriptomics.
  • Investigated the regulatory relationship between miR147 and its target Ndufa4.

Main Results:

  • miR147 is enriched in the colon, particularly in differentiated enterocytes.
  • Loss of miR147 led to increased intestinal inflammation and impaired mucosal healing in colitis models.
  • RNA sequencing revealed dysregulated immune signaling, including upregulated pro-inflammatory cytokines and reduced type I interferon responses.
  • Ndufa4 was identified as a direct miR147 target, with inverse expression patterns observed in murine and human colons.

Conclusions:

  • miR147 plays a protective role in intestinal homeostasis and mucosal healing.
  • Dysregulation of miR147 contributes to inflammatory bowel disease pathogenesis.
  • miR147 and its target Ndufa4 are involved in epithelial differentiation and metabolism.
  • miR147 represents a promising therapeutic target for inflammatory bowel disease.